About the ABC Score for Gastrointestinal Bleeding Mortality
The ABC score predicts 30-day mortality in acute gastrointestinal bleeding — upper or lower — from eight items grouped as Age, Blood tests and Comorbidities: age (1 point at 60–74, 2 at ≥75), urea > 10 mmol/L (1), albumin < 30 g/L (2), creatinine 100–150 µmol/L (1) or > 150 (2), altered mental status (2), liver cirrhosis (2), disseminated malignancy (4, the heaviest item) and ASA class III (1) or ≥ IV (3). It stratifies patients as low (≤ 3), medium (4–7) or high risk (≥ 8), with roughly 1%, 7% and 25% 30-day mortality in the derivation cohort. It was designed to predict death better than the older scores, and in validation it out-discriminates AIMS65 for mortality while working across both bleeding territories.
Formula
ABC = age points + urea points + albumin points + creatinine points + mental-status points + cirrhosis points + malignancy points + ASA points- age points
- 0 (<60), 1 (60–74), 2 (≥75).
- urea points
- 1 if > 10 mmol/L (BUN > ~28 mg/dL), else 0.
- albumin points
- 2 if < 30 g/L (< 3.0 g/dL), else 0.
- creatinine points
- 1 (100–150 µmol/L), 2 (> 150 µmol/L), else 0.
- mental-status points
- 2 if altered, else 0.
- cirrhosis points
- 2 if present, else 0.
- malignancy points
- 4 if disseminated malignancy, else 0.
- ASA points
- 1 (ASA III), 3 (ASA IV–V), else 0.
- Disseminated malignancy (4 points) is the heaviest single item — advanced cancer dominates 30-day prognosis after a GI bleed.
- Bands: ≤ 3 low, 4–7 medium, ≥ 8 high risk.
- Published thresholds are in SI units (urea mmol/L, albumin g/L, creatinine µmol/L); the calculator converts entered values so the comparisons remain exact whichever unit you use.
Interpreting the result
Read the band, not just the number. A low score (≤ 3) corresponds to roughly 1% 30-day mortality in the derivation cohort — a group that can generally be managed on a standard pathway. A medium score (4–7) corresponds to about 7% and warrants admission with active management and a clear escalation plan. A high score (≥ 8) corresponds to around 25% and should prompt a monitored bed, early senior and possibly critical-care involvement, and explicit goals-of-care discussion where advanced comorbidity is driving the score. External validation cohorts have reported somewhat higher absolute mortality in each band (about 2%, 13% and 27%), but the ordering and the clinical message are consistent.
| Score | Band | What it means | Action |
|---|---|---|---|
| 0–3 | Low risk | ≈ 1% 30-day mortality (derivation); ~2% in validation | Standard management pathway |
| 4–7 | Medium risk | ≈ 7% 30-day mortality (derivation); ~13% in validation | Admit, manage actively, set an escalation plan |
| ≥ 8 | High risk | ≈ 25% 30-day mortality (derivation); ~27% in validation | Monitored bed, early senior/critical-care input, goals-of-care where appropriate |
What the ABC Score needs (8 inputs)
- Age
- 1 point at 60–74 years, 2 points at 75 or over; 0 below 60. The 'A' of ABC.
- Urea
- 1 point if urea is above 10 mmol/L (equivalently BUN above about 28 mg/dL). A marker of both renal function and the volume of digested blood.
- Albumin
- 2 points if albumin is below 30 g/L (3.0 g/dL). Low albumin reflects chronic illness and frailty, and carries substantial weight.
- Creatinine
- 1 point at 100–150 µmol/L (about 1.13–1.70 mg/dL), 2 points above 150 µmol/L (> 1.70 mg/dL). Renal impairment is a strong independent predictor of death.
- Altered mental status
- 2 points. Flags either haemodynamic compromise or a serious comorbidity such as encephalopathy or sepsis.
- Liver cirrhosis
- 2 points. Cirrhosis raises mortality both directly and through variceal bleeding and coagulopathy.
- Disseminated malignancy
- 4 points — the single heaviest item, reflecting how strongly advanced cancer dominates 30-day prognosis.
- ASA physical status class
- 1 point for ASA III, 3 points for ASA IV–V; 0 for ASA I–II. A summary of overall systemic illness.
What it returns
- ABC score (0–18)
- The sum of the eight items. Higher scores indicate higher 30-day mortality.
- Risk band
- Low (≤ 3), medium (4–7) or high (≥ 8), each mapped to an approximate 30-day mortality.
How it is calculated
ABC is an integer points score derived by logistic regression on an international cohort and then simplified so each predictor carries a small whole-number weight. Its design choice — the reason it exists — is to foreground comorbidity: where AIMS65 leans on albumin, INR, blood pressure and age, ABC keeps age and simple labs but adds cirrhosis, disseminated malignancy, ASA class and altered mental status as explicit terms. Those comorbidity items are what let it predict death across both upper and lower GI bleeding, because much of the 30-day mortality after any GI bleed is determined by the patient's underlying illness rather than by the bleed itself.
Facts & figures
| Group | Item | Points |
|---|---|---|
| Age | 60–74 / ≥75 | 1 / 2 |
| Blood | Urea > 10 mmol/L | 1 |
| Blood | Albumin < 30 g/L | 2 |
| Blood | Creatinine 100–150 / >150 µmol/L | 1 / 2 |
| Comorbid | Altered mental status | 2 |
| Comorbid | Liver cirrhosis | 2 |
| Comorbid | Disseminated malignancy | 4 |
| Comorbid | ASA III / ASA IV–V | 1 / 3 |
Total 0–18. Bands: ≤3 low, 4–7 medium, ≥8 high.
| Band | Derivation | External validation |
|---|---|---|
| Low (≤3) | ~1% | ~2% |
| Medium (4–7) | ~7% | ~13% |
| High (≥8) | ~25% | ~27% |
Absolute rates vary by cohort; the risk ordering is stable.
Evidence
Derivation — international multicentre cohort
2021Derived by Laursen and colleagues from an international, multicentre cohort of patients with acute upper and lower gastrointestinal bleeding, selecting age, urea, albumin, creatinine, altered mental status, cirrhosis, disseminated malignancy and ASA class as independent predictors of 30-day mortality.
For upper GI bleeding the score discriminated 30-day mortality with an area under the ROC curve around 0.81, better than AIMS65 (~0.65) and the Glasgow-Blatchford score. Low, medium and high bands corresponded to roughly 1%, 7% and 25% mortality.
External validation — 30-day mortality
2022Independent validation of the ABC score for 30-day mortality in gastrointestinal bleeding, testing the low/medium/high bands in a separate cohort.
Reproduced the score's discrimination and the rising mortality gradient across bands (approximately 2%, 13% and 27%), confirming its performance outside the derivation population.
How it compares
ABC Score vs AIMS65 Score
ABC generally out-discriminates AIMS65 for 30-day mortality and works in lower as well as upper GI bleeding, at the cost of a few more inputs and explicit comorbidity terms.
AIMS65 is a five-item count that predicts in-hospital mortality from albumin, INR, mental status, blood pressure and age. ABC keeps age and simple labs but adds cirrhosis, disseminated malignancy and ASA class, which is why it captured more of the mortality signal in head-to-head derivation and validation (AUROC ~0.81 vs ~0.65 for upper GI bleeding in the derivation). AIMS65 remains attractive for its brevity; ABC is the stronger dedicated mortality score.
ABC Score vs Glasgow-Blatchford Score
Different jobs: Glasgow-Blatchford identifies low-risk upper GI bleeds who can avoid intervention or admission, while ABC predicts 30-day mortality across upper and lower bleeding — use them together, not interchangeably.
Glasgow-Blatchford is a sensitivity-tuned triage score that excels at finding patients who need no treatment, but it predicts death only weakly. ABC is purpose-built for mortality and adds the comorbidity terms that Glasgow-Blatchford lacks. In an upper GI bleed, a reasonable pattern is Glasgow-Blatchford for the disposition decision and ABC for the prognostic estimate.
Pearls & pitfalls
- ABC predicts 30-day mortality, not the need for intervention or safe discharge — pair it with Glasgow-Blatchford or Oakland for those questions.
- Disseminated malignancy alone contributes 4 points, enough to reach the medium band, which is appropriate but means the score is heavily comorbidity-driven.
- Check units: the thresholds are urea > 10 mmol/L, albumin < 30 g/L and creatinine 100–150 / > 150 µmol/L. Entering BUN in mg/dL or albumin in g/dL without converting will misscore.
- It works in both upper and lower GI bleeding, one of its main advantages over AIMS65 and Glasgow-Blatchford.
- Absolute mortality per band runs higher in some validation cohorts than in the derivation; use the bands to rank risk rather than to quote a precise percentage.
- A high score often reflects advanced underlying disease, so it should prompt a goals-of-care conversation as well as escalation of bleeding management.
Critical actions
- Confirm the ASA class and comorbidities deliberately — cirrhosis, disseminated malignancy and altered mental status carry most of the weight and are easy to under-record.
- Convert labs to the score's units (urea mmol/L, albumin g/L, creatinine µmol/L) or use the calculator's unit toggles so the thresholds apply correctly.
- Escalate high-band patients (≥ 8) to a monitored setting with early senior input, and consider critical care.
- Calculate Glasgow-Blatchford (upper) or Oakland (lower) alongside ABC when the decision is admission, intervention or discharge rather than prognosis.
- Where a high score is driven by advanced malignancy or end-stage disease, discuss goals of care in parallel with resuscitation.
Why this score exists
The authors built ABC because the scores in daily use were optimised for other questions — Glasgow-Blatchford for intervention and safe discharge, Rockall for a mixed prognostic picture — leaving mortality prediction as a secondary, weaker output. Their deliberate move was to make comorbidity explicit: disseminated malignancy, cirrhosis, ASA class and altered mental status enter as named terms rather than being folded into a single 'comorbidity' category, and disseminated malignancy is weighted heaviest because it dominates short-term prognosis. Extending the derivation across both upper and lower GI bleeding was equally intentional, giving a single mortality score usable before the source is known.
About the creator
First author, 2021 derivation and validation study
Led the international multicentre work that derived the ABC score across Danish, UK, Italian and Spanish cohorts.
Senior author
Also a co-author on the wider body of upper-GI bleeding risk-score validation, including comparisons against Glasgow-Blatchford.
Limitations
- It predicts mortality only, and gives no information on rebleeding, transfusion need, intervention or safe discharge.
- It is heavily weighted towards comorbidity, so a frail patient with a trivial bleed can score high — clinically true but occasionally counterintuitive.
- Absolute mortality per band varies between cohorts, so the bands are better used for stratification than for precise counselling.
- The comorbidity items (cirrhosis, disseminated malignancy, ASA) require accurate history and can be under-documented in a rushed presentation.
- As a newer score it has less accumulated real-world validation than AIMS65, Rockall or Glasgow-Blatchford, though the evidence base is growing.
If you are the patient
The ABC score estimates the risk of dying within a month after bleeding from the gut, whether the bleeding is from the upper or lower part. Its name stands for Age, Blood tests and Comorbidities: it adds up your age, a few blood results (kidney tests and a protein called albumin), and other health conditions such as liver cirrhosis, advanced cancer, confusion, and overall fitness for anaesthesia. The total sorts people into low, medium or high risk — roughly a 1-in-100, 1-in-14, or 1-in-4 chance of dying within 30 days in the original study — which helps the team decide how closely to watch you and how urgently to involve senior doctors. It measures overall risk to life rather than whether the bleeding will stop, so it is used alongside other scores that answer those separate questions.
Frequently asked questions
What is the ABC score for GI bleeding?#
The ABC score (Age, Blood tests, Comorbidities) predicts 30-day mortality in acute upper or lower gastrointestinal bleeding. It scores age, urea, albumin, creatinine, altered mental status, liver cirrhosis, disseminated malignancy and ASA class, and sorts patients into low (≤3), medium (4–7) and high (≥8) risk.
What are the ABC score risk categories?#
Low risk is a score of 3 or below (about 1% 30-day mortality in the derivation cohort), medium risk is 4 to 7 (about 7%), and high risk is 8 or above (about 25%). External validation reported somewhat higher rates — roughly 2%, 13% and 27% — but the same ordering.
Is the ABC score better than AIMS65?#
For predicting mortality, yes in most studies. ABC was derived after AIMS65 and adds explicit comorbidity terms; in the derivation it discriminated 30-day mortality in upper GI bleeding better than AIMS65 (AUROC around 0.81 versus 0.65). AIMS65 is simpler, but ABC is the stronger dedicated mortality score and also covers lower GI bleeding.
Does the ABC score work for lower GI bleeding?#
Yes. Unlike AIMS65 and the Glasgow-Blatchford score, ABC was derived and validated in both upper and lower gastrointestinal bleeding, so it can be applied before the bleeding source is confirmed.
What units does the ABC score use?#
The published thresholds are in SI units: urea above 10 mmol/L, albumin below 30 g/L, and creatinine of 100–150 or above 150 µmol/L. If your laboratory reports BUN in mg/dL or albumin in g/dL, convert first or use the calculator's unit toggle so the thresholds apply correctly.
Which item carries the most points?#
Disseminated malignancy, at 4 points — enough on its own to reach the medium-risk band. This reflects how strongly advanced cancer dominates 30-day prognosis after a gastrointestinal bleed.
References
Original / primary reference
Clinical practice guidelines
- Laine L, Barkun AN, Saltzman JR, Martel M, Leontiadis GI. ACG Clinical Guideline: Upper Gastrointestinal and Ulcer Bleeding. Am J Gastroenterol. 2021;116(5):899-917.
- Oakland K, Chadwick G, East JE, et al. Diagnosis and management of acute lower gastrointestinal bleeding: guidelines from the British Society of Gastroenterology. Gut. 2019;68(5):776-789.
Further reading
- Saltzman JR, Tabak YP, Hyett BH, Sun X, Travis AC, Johannes RS. A simple risk score accurately predicts in-hospital mortality, length of stay, and cost in acute upper GI bleeding. Gastrointest Endosc. 2011;74(6):1215-1224.
- Blatchford O, Murray WR, Blatchford M. A risk score to predict need for treatment for upper-gastrointestinal haemorrhage. Lancet. 2000;356(9238):1318-1321.